Ledger.Open graph →
SEC Form D · filed March 20, 2020

RECODE THERAPEUTICS, INC

Offering
$80.0M
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MENLO PARK, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Helen S. Kim · Menlo Park, CADirectorEdward S. Hurwitz · Menlo Park, CADirectorDavid S. Lockhart · Menlo Park, CAExec · DirectorPeter A. Thompson · Menlo Park, CADirectorRa S. Session Ii · Menlo Park, CADirectorKaren Mcginnis · San Diego, CADirectorMark Prather · DENVER, COExec · DirectorPeter Hudson · DENVER, CODirectorDominic Bagnoli · DENVER, CODirectorRyan Drant · DENVER, CODirectorMichael J. Torres · Menlo Park, CADirectorZachary Morrison · New York, NYExec · DirectorKaitlin Stephens · New York, NYDirectorCory A. Carlson · Seattle, WADirectorJeff Fenster · Vista, CADirectorMartin A. Klingel, Jr · Carmel, CADirectorMichael J. Torres · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗